Skip to main content
Premium Trial:

Request an Annual Quote

Estonian DNA Center to Begin Receiving Samples This Month

NEW YORK, Sept. 9 - A DNA-sample facility jointly run by the Estonian Genome Project Foundation and the California company EGeen is set to receive its first batch of samples this month.

 

The partners said 10,000 DNA samples collected from three Estonian counties will arrive in the first half of September at the Tartu facility, which opened last week. This initial run will act as the first pancake of the three-year-long EGP project, the partners said. Nationwide collection will follow at an undisclosed time.

 

EGeen, based in Redwood City, Calif., has exclusive commercial rights to data compiled in the Estonian Genome Project, a government program designed to gather medical data and DNA samples from "a significant portion" of the 1.4 million people who live in this former Soviet-bloc country.

 

Privately held EGeen said it will use these data for drug and diagnostic discovery.

 

Click here for more information.

The Scan

Removal Inquiry

The Wall Street Journal reports that US lawmakers are seeking additional information about the request to remove SARS-CoV-2 sequence data from a database run by the National Institutes of Health.

Likely to End in Spring

Free lateral flow testing for SARS-CoV-2 may end in the UK by next spring, the head of Innova Medical Group says, according to the Financial Times.

Searching for More Codes

NPR reports that the US Department of Justice has accused an insurance and a data mining company of fraud.

Genome Biology Papers on GWAS Fine-Mapping Method, COVID-19 Susceptibility, Rheumatoid Arthritis

In Genome Biology this week: integrative fine-mapping approach, analysis of locus linked to COVID-19 susceptibility and severity, and more.